Siddhartha Kadia

Siddhartha C.
Kadia is President, Chief Executive Officer & Director at Mesa Laboratories, Inc. since 2026.
Holds positions as Independent Non-Executive Director at ALS Ltd. since 2019, Director at BioSkryb, Inc. since 2020, Director at Applied Technical Services LLC since 2021, Director at SeQure DX, Inc., and Member-Overseers Board at The Scripps Research Institute.
Former roles include President, Chief Executive Officer & Director at Evans Analytical Group LLC; President, Chief Executive Officer & Director at Eurofins BioPharma Product Testing Columbia, Inc. from 2014 to 2018; President & Chief Executive Officer at Eurofins EAG Agroscience LLC from 2014 to 2018; Chief Executive Officer & Director at Bruker Cellular Analysis, Inc. from 2022 to 2023; Chief Executive Officer & Director at Phenomebio, Inc. from 2022 to 2023; Chief Executive Officer & Director at Calibre Scientific, Inc.; Independent Director at Newport Corp.
from 2014 to 2016; Independent Director at NuVasive LLC from 2021 to 2023; Independent Director at Philips Image Guided Therapy Corp.
from 2013 to 2015; Independent Director at IsoPlexis Corp.; Non-Executive Director at Horizon Discovery Group Ltd. in 2020; Independent Director at VIDA FLaSH Acquisitions; Director at Bioskryb Genomics, Inc.; Vice President-Global Marketing & eBusiness at Invitrogen Corp.
from 2005 to 2008; Neuroscientist at The Johns Hopkins University; President-Life Sciences Division at Life Technologies Corp.
from 2013 to 2014.
Education includes graduate studies at Rutgers State University of New Jersey, undergraduate studies at Gujarat University, and a doctorate from The Johns Hopkins University School of Medicine.